BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE was reported 2325 times

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABSTAINS FROM RECREATIONAL DRUGS 1 0.3333
1 BODY MASS INDEX 1 0.0526
2 NEURONAL NEUROPATHY 1 0.0476
3 NEUROSTIMULATOR REMOVAL 1 0.0417
4 NEONATAL COMPLICATIONS OF SUBSTANCE ABUSE 1 0.0385
5 DISSEMINATED GONOCOCCAL INFECTION 1 0.0370
6 ANTIDEPRESSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0345
7 TOOTH EROSION 29 0.0237
8 DRUG DEPENDENCE, ANTEPARTUM 1 0.0192
9 MISCARRIAGE OF PARTNER 1 0.0182
10 PRODUCT DOSAGE FORM ISSUE 7 0.0145
11 LOOSE ASSOCIATIONS 1 0.0139
12 ANTICHOLINERGIC EFFECT 1 0.0133
13 PILOERECTION 14 0.0128
14 CONGENITAL HEARING DISORDER 2 0.0123
15 VISION ABNORMAL NEONATAL 5 0.0120
16 PRODUCT SOLUBILITY ABNORMAL 53 0.0105
17 EYELID MYOCLONUS 1 0.0100
18 GLOMERULONEPHRITIS ACUTE 2 0.0097
19 CENTRAL SLEEP APNOEA SYNDROME 3 0.0092
20 LEARNING DISABILITY 48 0.0090
21 DRUG DETOXIFICATION 8 0.0089
22 SYMPATHOMIMETIC EFFECT 2 0.0087
23 NEONATAL HYPOACUSIS 2 0.0084
24 BED BUG INFESTATION 1 0.0079
25 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 4 0.0074
26 DRUG WITHDRAWAL MAINTENANCE THERAPY 1 0.0071
27 HETEROPHORIA 1 0.0069
28 POOR DENTAL CONDITION 2 0.0068
29 INFECTIVE GLOSSITIS 1 0.0064
30 DENTAL CARIES 70 0.0063
31 SEASONAL AFFECTIVE DISORDER 2 0.0063
32 NEPHROANGIOSCLEROSIS 1 0.0062
33 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
34 SALIVARY GLAND ENLARGEMENT 3 0.0057
35 DEVELOPMENTAL DELAY 51 0.0056
36 DENTAL RESTORATION FAILURE 4 0.0055
37 DRUG WITHDRAWAL SYNDROME NEONATAL 82 0.0055
38 SUSPECTED PRODUCT TAMPERING 3 0.0053
39 GLOMERULONEPHRITIS CHRONIC 1 0.0053
40 YAWNING 14 0.0052
41 CORTISOL ABNORMAL 1 0.0050
42 DRUG DIVERSION 31 0.0050
43 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 2 0.0049
44 LICE INFESTATION 1 0.0048
45 DRUG SCREEN NEGATIVE 8 0.0045
46 EATING DISORDER SYMPTOM 2 0.0043
47 MANUFACTURING ISSUE 2 0.0043
48 ANORECTAL OPERATION 1 0.0042
49 DEVICE INTOLERANCE 1 0.0042
50 OPIATES POSITIVE 2 0.0042
51 CHILD NEGLECT 1 0.0041
52 MULTIPLE DRUG THERAPY 3 0.0040
53 PRODUCT TAMPERING 7 0.0039
54 GINGIVAL EROSION 1 0.0039
55 CHILD ABUSE 1 0.0039
56 CYANOSIS CENTRAL 1 0.0038
57 CRIME 1 0.0038
58 TOBACCO ABUSE 2 0.0037
59 INFUSION SITE THROMBOSIS 1 0.0037
60 EAR INFECTION BACTERIAL 1 0.0037
61 TONGUE ERYTHEMA 3 0.0036
62 IRREGULAR BREATHING 2 0.0034
63 HYPERTENSIVE EMERGENCY 4 0.0034
64 ELBOW OPERATION 2 0.0032
65 INCREASED DOSE ADMINISTERED 1 0.0032
66 HYPERAESTHESIA TEETH 4 0.0032
67 PRODUCT AFTER TASTE 3 0.0031
68 SOCIAL ANXIETY DISORDER 2 0.0030
69 GINGIVAL DISCOMFORT 2 0.0030
70 HYPOGONADISM 3 0.0030
71 FOETAL HYPOKINESIA 2 0.0029
72 ANDROGEN DEFICIENCY 1 0.0028
73 CRYOGLOBULINAEMIA 2 0.0028
74 WITHDRAWAL SYNDROME 117 0.0028
75 ANKLE ARTHROPLASTY 1 0.0028
76 CEREBRAL MASS EFFECT 1 0.0028
77 BODY DYSMORPHIC DISORDER 1 0.0027
78 JAUNDICE NEONATAL 5 0.0026
79 ACUTE PHASE REACTION 1 0.0026
80 CEREBELLAR STROKE 1 0.0026
81 DROPPED HEAD SYNDROME 1 0.0025
82 DRUG WITHDRAWAL SYNDROME 217 0.0025
83 BASAL GANGLIA HAEMORRHAGE 2 0.0025
84 DRUG WITHDRAWAL HEADACHE 1 0.0024
85 GLUCOCORTICOID DEFICIENCY 1 0.0024
86 INTENTIONAL UNDERDOSE 17 0.0023
87 GINGIVAL BLISTER 1 0.0023
88 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 14 0.0023
89 HOMELESS 1 0.0022
90 TONGUE BLISTERING 5 0.0022
91 SUBSTANCE ABUSE 18 0.0022
92 ORAL ADMINISTRATION COMPLICATION 2 0.0022
93 PULPITIS DENTAL 2 0.0021
94 ARTIFICIAL CROWN PROCEDURE 1 0.0020
95 MYELOID LEUKAEMIA 1 0.0020
96 EXPOSURE VIA PARTNER 1 0.0020
97 LEUKOPLAKIA ORAL 1 0.0019
98 ORAL MUCOSAL ERYTHEMA 3 0.0019
99 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
100 TOOTH FRACTURE 21 0.0019
101 INFUSION SITE CELLULITIS 1 0.0019
102 NON-CARDIOGENIC PULMONARY OEDEMA 2 0.0019
103 PERIODONTITIS 4 0.0018
104 TOOTH LOSS 38 0.0018
105 HYPERTENSIVE URGENCY 1 0.0018
106 DRUG USE DISORDER 15 0.0018
107 TONGUE ULCERATION 6 0.0018
108 BURNING MOUTH SYNDROME 1 0.0018
109 DRUG EFFECT VARIABLE 2 0.0018
110 BURN ORAL CAVITY 1 0.0017
111 ADMINISTRATION SITE PAIN 2 0.0017
112 MENTAL DISABILITY 1 0.0017
113 HEPATITIS C VIRUS TEST POSITIVE 1 0.0017
114 BLOOD OESTROGEN INCREASED 1 0.0017
115 GLOSSITIS 6 0.0017
116 NEURODEGENERATIVE DISORDER 1 0.0016
117 BLADDER DISCOMFORT 2 0.0016
118 BREECH PRESENTATION 2 0.0016
119 ANION GAP 1 0.0016
120 ENDODONTIC PROCEDURE 4 0.0016
121 EUPHORIC MOOD 16 0.0016
122 ENTEROCOCCUS TEST POSITIVE 1 0.0015
123 POTENTIATING DRUG INTERACTION 5 0.0015
124 PRODUCT SUBSTITUTION ISSUE 85 0.0015
125 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
126 DRUG DEPENDENCE 235 0.0015
127 TACHYPHRENIA 5 0.0014
128 ORAL DISCOMFORT 20 0.0014
129 PERIODONTAL DISEASE 2 0.0014
130 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
131 ALCOHOL INTOLERANCE 1 0.0014
132 CARDIAC SEPTAL DEFECT 1 0.0014
133 DRUG SCREEN POSITIVE 11 0.0014
134 NASAL INJURY 1 0.0014
135 DISSOCIATIVE DISORDER 1 0.0014
136 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
137 GENERALISED ANXIETY DISORDER 2 0.0014
138 LEGAL PROBLEM 1 0.0014
139 BLUNTED AFFECT 1 0.0014
140 AMPHETAMINES POSITIVE 1 0.0013
141 MICTURITION FREQUENCY DECREASED 1 0.0013
142 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
143 INJECTION SITE REACTION 91 0.0013
144 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
145 LIMB ASYMMETRY 1 0.0013
146 GINGIVAL DISORDER 5 0.0013
147 EXTRADURAL ABSCESS 1 0.0013
148 INAPPROPRIATE AFFECT 2 0.0013
149 LIP ERYTHEMA 1 0.0013
150 SELF ESTEEM DECREASED 3 0.0012
151 RESPIRATORY DISORDER NEONATAL 2 0.0012
152 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
153 RESTLESS LEGS SYNDROME 22 0.0012
154 COVID-19 IMMUNISATION 1 0.0012
155 DRUG TOLERANCE 6 0.0012
156 INFECTED BITE 1 0.0012
157 TONGUE DISCOMFORT 5 0.0012
158 LIP PRURITUS 1 0.0012
159 DEVICE LOOSENING 1 0.0012
160 HYPOPNOEA 4 0.0012
161 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
162 ACUTE CHEST SYNDROME 1 0.0011
163 GINGIVITIS 6 0.0011
164 CLONUS 3 0.0011
165 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
166 HOMICIDE 2 0.0011
167 FEELING DRUNK 8 0.0011
168 TUNNEL VISION 2 0.0011
169 FOETAL EXPOSURE DURING PREGNANCY 86 0.0011
170 TOOTHACHE 19 0.0010
171 DRUG ABUSE 87 0.0010
172 GINGIVAL RECESSION 2 0.0010
173 HYPERVIGILANCE 1 0.0010
174 PRODUCT TASTE ABNORMAL 14 0.0010
175 STRESS CARDIOMYOPATHY 6 0.0010
176 ALCOHOL INTERACTION 2 0.0010
177 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
178 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
179 DILATED CARDIOMYOPATHY 1 0.0010
180 AUTONOMIC NEUROPATHY 1 0.0010
181 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
182 COLD SWEAT 17 0.0010
183 OEDEMA MUCOSAL 1 0.0010
184 FOETAL DISTRESS SYNDROME 2 0.0009
185 NEUROMYOPATHY 1 0.0009
186 PANCREATIC MASS 1 0.0009
187 LOOSE TOOTH 3 0.0009
188 GALLBLADDER ENLARGEMENT 1 0.0009
189 FAECALOMA 5 0.0009
190 PRODUCT FORMULATION ISSUE 6 0.0009
191 CLEFT LIP AND PALATE 1 0.0009
192 HALO VISION 1 0.0009
193 REACTION TO EXCIPIENT 2 0.0009
194 METHAEMOGLOBINAEMIA 2 0.0009
195 HYPERREFLEXIA 3 0.0009
196 MAJOR DEPRESSION 6 0.0008
197 FEBRILE CONVULSION 1 0.0008
198 THERAPY CHANGE 8 0.0008
199 MALIGNANT MELANOMA IN SITU 1 0.0008
200 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
201 CAROTID ARTERY DISEASE 1 0.0008
202 INSURANCE ISSUE 12 0.0008
203 INFUSION SITE IRRITATION 1 0.0008
204 DRUG TITRATION ERROR 2 0.0008
205 LIBIDO DISORDER 1 0.0008
206 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
207 ORAL INFECTION 3 0.0008
208 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
209 RENAL PAIN 8 0.0008
210 HYPERHIDROSIS 97 0.0008
211 ALCOHOL ABUSE 2 0.0007
212 RESTLESSNESS 27 0.0007
213 PRODUCT PACKAGING ISSUE 7 0.0007
214 BIPOLAR DISORDER 8 0.0007
215 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 149 0.0007
216 AGORAPHOBIA 1 0.0007
217 SEROTONIN SYNDROME 14 0.0007
218 DRUG SCREEN FALSE POSITIVE 2 0.0007
219 FORMICATION 5 0.0007
220 RENAL TUBULAR DISORDER 2 0.0007
221 CATAPLEXY 1 0.0007
222 CONNECTIVE TISSUE DISORDER 1 0.0007
223 PRODUCT DISPENSING ISSUE 3 0.0007
224 GENITAL RASH 1 0.0007
225 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
226 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
227 TOOTH INJURY 3 0.0007
228 DRUG LEVEL DECREASED 7 0.0007
229 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
230 NEGATIVE THOUGHTS 2 0.0007
231 ORAL DISORDER 5 0.0007
232 ACUTE ABDOMEN 1 0.0007
233 PHYSICAL DISABILITY 3 0.0007
234 DECREASED INTEREST 4 0.0007
235 GENITAL PAIN 1 0.0007
236 INFUSION SITE INDURATION 1 0.0007
237 AXILLARY PAIN 1 0.0007
238 IMPETIGO 1 0.0007
239 CARDIO-RESPIRATORY ARREST 28 0.0007
240 URINE ANALYSIS ABNORMAL 2 0.0007
241 LOSS OF EMPLOYMENT 2 0.0007
242 MASTICATION DISORDER 2 0.0007
243 ORAL MUCOSAL ERUPTION 1 0.0007
244 GASTROSTOMY 1 0.0006
245 PRODUCT DISPENSING ERROR 14 0.0006
246 PRE-EXISTING CONDITION IMPROVED 4 0.0006
247 ONYCHOLYSIS 1 0.0006
248 RESPIRATORY RATE DECREASED 2 0.0006
249 THERAPEUTIC RESPONSE CHANGED 4 0.0006
250 SUBSTANCE USE DISORDER 2 0.0006
251 IMPAIRED QUALITY OF LIFE 9 0.0006
252 EXPOSURE TO TOXIC AGENT 2 0.0006
253 AORTIC VALVE DISEASE 1 0.0006
254 IMPAIRED DRIVING ABILITY 7 0.0006
255 OROPHARYNGEAL BLISTERING 1 0.0006
256 HYPOVENTILATION 2 0.0006
257 NEAR DEATH EXPERIENCE 2 0.0006
258 DRUG EFFECT INCOMPLETE 22 0.0006
259 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
260 COLITIS ISCHAEMIC 4 0.0006
261 CEREBELLAR INFARCTION 1 0.0006
262 THINKING ABNORMAL 11 0.0006
263 INADEQUATE ANALGESIA 5 0.0006
264 ABNORMAL LOSS OF WEIGHT 4 0.0006
265 LAZINESS 1 0.0006
266 ORAL PAIN 13 0.0006
267 PRIAPISM 2 0.0006
268 MEDICAL DEVICE REMOVAL 1 0.0006
269 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
270 HYPOPITUITARISM 1 0.0006
271 PRODUCT USE COMPLAINT 9 0.0006
272 RESPIRATORY DEPRESSION 7 0.0006
273 INFUSION SITE DISCHARGE 1 0.0006
274 MOUTH ULCERATION 12 0.0006
275 HANGOVER 2 0.0006
276 LOGORRHOEA 2 0.0006
277 HEART DISEASE CONGENITAL 2 0.0006
278 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
279 OBSESSIVE THOUGHTS 1 0.0006
280 TONGUE DISORDER 4 0.0006
281 DEVICE ALARM ISSUE 1 0.0006
282 APATHY 8 0.0005
283 ESSENTIAL HYPERTENSION 1 0.0005
284 PRODUCT PRESCRIBING ERROR 13 0.0005
285 PRODUCT PHYSICAL ISSUE 11 0.0005
286 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
287 OESOPHAGEAL SPASM 1 0.0005
288 DISORGANISED SPEECH 1 0.0005
289 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
290 ACCIDENTAL DEATH 1 0.0005
291 TOOTH INFECTION 7 0.0005
292 HYPOREFLEXIA 1 0.0005
293 DELIRIUM 18 0.0005
294 CLEFT PALATE 1 0.0005
295 CONVERSION DISORDER 1 0.0005
296 FAECES HARD 2 0.0005
297 SWOLLEN TONGUE 16 0.0005
298 SEXUAL DYSFUNCTION 6 0.0005
299 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
300 EMPYEMA 1 0.0005
301 FUNGAL SKIN INFECTION 2 0.0005
302 SPINAL FUSION SURGERY 2 0.0005
303 TOOTH ABSCESS 5 0.0005
304 PERIPHERAL ISCHAEMIA 2 0.0005
305 TRIGGER FINGER 2 0.0005
306 HYPERAESTHESIA 4 0.0005
307 PRODUCT PREPARATION ERROR 10 0.0005
308 SELF-MEDICATION 2 0.0005
309 EXPOSURE DURING PREGNANCY 30 0.0005
310 IMPAIRED SELF-CARE 1 0.0005
311 SUICIDAL BEHAVIOUR 2 0.0005
312 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
313 NEUROGENIC BLADDER 1 0.0005
314 EYE CONTUSION 1 0.0005
315 EAR SWELLING 1 0.0005
316 SLEEP APNOEA SYNDROME 9 0.0005
317 MYDRIASIS 6 0.0005
318 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
319 RHINORRHOEA 29 0.0004
320 POST-TRAUMATIC STRESS DISORDER 3 0.0004
321 FEAR OF DEATH 1 0.0004
322 ANAL INCONTINENCE 4 0.0004
323 WRONG PRODUCT ADMINISTERED 3 0.0004
324 VASCULAR DEVICE INFECTION 2 0.0004
325 PREMATURE DELIVERY 7 0.0004
326 BLOOD TESTOSTERONE DECREASED 3 0.0004
327 MENTAL DISORDER 19 0.0004
328 RESPIRATION ABNORMAL 3 0.0004
329 MUSCLE TWITCHING 10 0.0004
330 LOCALISED OEDEMA 2 0.0004
331 ROSACEA 2 0.0004
332 FEELING OF DESPAIR 2 0.0004
333 SUSPECTED SUICIDE 2 0.0004
334 DYSMORPHISM 1 0.0004
335 RETCHING 9 0.0004
336 PRE-ECLAMPSIA 2 0.0004
337 ANXIETY 119 0.0004
338 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75 0.0004
339 HUMERUS FRACTURE 2 0.0004
340 DRUG INTOLERANCE 40 0.0004
341 RASH VESICULAR 2 0.0004
342 HORMONE LEVEL ABNORMAL 2 0.0004
343 DENTAL OPERATION 1 0.0004
344 TOOTH DISORDER 9 0.0004
345 ACUTE PSYCHOSIS 1 0.0004
346 INJECTION SITE ABSCESS 1 0.0004
347 SALIVARY HYPERSECRETION 4 0.0004
348 HYPERPARATHYROIDISM SECONDARY 1 0.0004
349 TOXIC ENCEPHALOPATHY 2 0.0004
350 HOSTILITY 1 0.0004
351 PHARYNGEAL OEDEMA 6 0.0004
352 CATATONIA 2 0.0004
353 HALLUCINATION, VISUAL 8 0.0004
354 ALCOHOL POISONING 1 0.0004
355 PRODUCT SIZE ISSUE 2 0.0004
356 LARYNGOSPASM 1 0.0004
357 FEELING ABNORMAL 89 0.0004
358 BRUXISM 2 0.0004
359 EAR CONGESTION 1 0.0004
360 BACK INJURY 4 0.0004
361 FEELING JITTERY 7 0.0004
362 CLUMSINESS 1 0.0004
363 LACRIMATION INCREASED 11 0.0004
364 MENTAL STATUS CHANGES 10 0.0004
365 EJACULATION DISORDER 1 0.0004
366 PRODUCT AVAILABILITY ISSUE 8 0.0004
367 FIBULA FRACTURE 1 0.0003
368 PARAESTHESIA ORAL 5 0.0003
369 PARAPLEGIA 1 0.0003
370 THERAPEUTIC RESPONSE DECREASED 21 0.0003
371 EYELID MARGIN CRUSTING 1 0.0003
372 NECK INJURY 1 0.0003
373 AGITATION 25 0.0003
374 ILLNESS 35 0.0003
375 HEAD DISCOMFORT 6 0.0003
376 SUICIDAL IDEATION 31 0.0003
377 INFUSION SITE REACTION 1 0.0003
378 ACNE CYSTIC 1 0.0003
379 HYPERCAPNIA 1 0.0003
380 HEPATITIS C 4 0.0003
381 EMOTIONAL DISTRESS 40 0.0003
382 STOMATITIS 20 0.0003
383 VOMITING 155 0.0003
384 PANIC ATTACK 12 0.0003
385 DYSCHEZIA 1 0.0003
386 IMPAIRED WORK ABILITY 7 0.0003
387 DUODENITIS 1 0.0003
388 FIBROSIS 1 0.0003
389 IRON DEFICIENCY ANAEMIA 3 0.0003
390 FEELING COLD 9 0.0003
391 MULTIPLE-DRUG RESISTANCE 1 0.0003
392 TOOTH EXTRACTION 4 0.0003
393 TOXICITY TO VARIOUS AGENTS 54 0.0003
394 BLOOD CREATININE DECREASED 1 0.0003
395 BRAIN FOG 5 0.0003
396 NAUSEA 251 0.0003
397 NON-CARDIAC CHEST PAIN 1 0.0003
398 IRRITABILITY 19 0.0003
399 SCREAMING 2 0.0003
400 GLOSSODYNIA 7 0.0003
401 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
402 ROAD TRAFFIC ACCIDENT 13 0.0003
403 OVERDOSE 67 0.0003
404 PRODUCT QUALITY ISSUE 42 0.0003
405 INJECTION SITE INDURATION 4 0.0003
406 HEPATITIS ACUTE 2 0.0003
407 FACET JOINT SYNDROME 1 0.0003
408 PHARYNGEAL SWELLING 3 0.0003
409 INFUSION SITE HAEMORRHAGE 1 0.0003
410 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
411 MATERNAL EXPOSURE DURING PREGNANCY 27 0.0003
412 EXPOSURE DURING BREAST FEEDING 1 0.0003
413 COMPLETED SUICIDE 25 0.0003
414 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
415 PRODUCT ADMINISTRATION ERROR 6 0.0003
416 ULCER HAEMORRHAGE 2 0.0003
417 RESPIRATORY ARREST 8 0.0003
418 CERVICAL VERTEBRAL FRACTURE 1 0.0003
419 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
420 BLOOD CREATININE ABNORMAL 1 0.0003
421 FIBROMYALGIA 7 0.0003
422 EXTRASYSTOLES 2 0.0003
423 DEMENTIA 8 0.0003
424 TREMOR 47 0.0003
425 MIGRAINE 27 0.0003
426 CHILLS 33 0.0003
427 HAEMORRHAGIC DIATHESIS 1 0.0003
428 POOR QUALITY SLEEP 6 0.0003
429 PHARYNGITIS STREPTOCOCCAL 3 0.0003
430 OSTEOMYELITIS 5 0.0003
431 PRODUCT PRESCRIBING ISSUE 6 0.0003
432 MONOCYTE COUNT INCREASED 1 0.0003
433 DYSSTASIA 8 0.0003
434 DEPENDENCE 15 0.0003
435 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
436 FOOD INTOLERANCE 1 0.0003
437 PARADOXICAL DRUG REACTION 1 0.0003
438 UNRESPONSIVE TO STIMULI 7 0.0003
439 PSYCHIATRIC SYMPTOM 2 0.0003
440 DYSKINESIA 11 0.0003
441 CEREBRAL DISORDER 2 0.0003
442 MALNUTRITION 3 0.0003
443 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
444 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
445 PARANASAL SINUS DISCOMFORT 1 0.0003
446 INSOMNIA 70 0.0003
447 CLAVICLE FRACTURE 1 0.0003
448 DRY MOUTH 21 0.0003
449 CONGENITAL ANOMALY 2 0.0003
450 CARDIOPULMONARY FAILURE 1 0.0003
451 HYPOXIA 9 0.0003
452 TORSADE DE POINTES 2 0.0003
453 NAIL DISCOLOURATION 1 0.0003
454 DISABILITY 5 0.0003
455 RENAL CYST 2 0.0003
456 HALLUCINATION, AUDITORY 4 0.0003
457 GINGIVAL PAIN 2 0.0003
458 EXPOSURE VIA BREAST MILK 1 0.0003
459 OBESITY 4 0.0003
460 ADVERSE EVENT 23 0.0002
461 MIOSIS 2 0.0002
462 UTERINE CANCER 2 0.0002
463 NERVOUSNESS 13 0.0002
464 SOMNOLENCE 50 0.0002
465 NIGHT SWEATS 8 0.0002
466 MENTAL IMPAIRMENT 6 0.0002
467 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
468 TASTE DISORDER 5 0.0002
469 DEPRESSION 56 0.0002
470 POST PROCEDURAL INFECTION 2 0.0002
471 HEADACHE 154 0.0002
472 INTENTIONAL DOSE OMISSION 7 0.0002
473 SMALL INTESTINAL OBSTRUCTION 3 0.0002
474 ARTHRITIS BACTERIAL 1 0.0002
475 LETHARGY 14 0.0002
476 INJECTION SITE EXTRAVASATION 3 0.0002
477 MANIA 4 0.0002
478 LEG AMPUTATION 1 0.0002
479 GENERALISED OEDEMA 3 0.0002
480 TREATMENT FAILURE 20 0.0002
481 DRUG EFFECT DECREASED 13 0.0002
482 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
483 EOSINOPHIL COUNT INCREASED 2 0.0002
484 HALLUCINATIONS, MIXED 1 0.0002
485 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
486 MUSCLE FATIGUE 1 0.0002
487 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
488 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
489 FACIAL PARALYSIS 2 0.0002
490 INTERVERTEBRAL DISC DISORDER 1 0.0002
491 ALCOHOLISM 1 0.0002
492 BLISTER 13 0.0002
493 MONOPLEGIA 1 0.0002
494 IMMOBILE 1 0.0002
495 PRODUCT USE ISSUE 43 0.0002
496 BEDRIDDEN 3 0.0002
497 IMMUNE SYSTEM DISORDER 3 0.0002
498 GINGIVAL SWELLING 1 0.0002
499 QUALITY OF LIFE DECREASED 3 0.0002
500 GASTROINTESTINAL DISORDER 20 0.0002
501 SNEEZING 5 0.0002
502 LIMB INJURY 6 0.0002
503 TACHYPNOEA 3 0.0002
504 MOOD ALTERED 6 0.0002
505 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
506 HIDRADENITIS 2 0.0002
507 IMMUNE THROMBOCYTOPENIA 1 0.0002
508 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
509 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
510 INCREASED TENDENCY TO BRUISE 2 0.0002
511 DYSURIA 8 0.0002
512 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
513 NEPHROGENIC ANAEMIA 1 0.0002
514 RHABDOMYOLYSIS 9 0.0002
515 ARTHRITIS INFECTIVE 1 0.0002
516 PERSONALITY CHANGE 2 0.0002
517 NEPHROPATHY 2 0.0002
518 DEFORMITY 2 0.0002
519 DEVICE OCCLUSION 3 0.0002
520 SEASONAL ALLERGY 3 0.0002
521 ENDOMETRIOSIS 1 0.0002
522 HYPERSOMNIA 6 0.0002
523 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
524 LIMB OPERATION 1 0.0002
525 DRUG PRESCRIBING ERROR 4 0.0002
526 APHAGIA 1 0.0002
527 MALAISE 91 0.0002
528 ANGER 7 0.0002
529 PRESCRIBED OVERDOSE 4 0.0002
530 INTENTIONAL PRODUCT MISUSE 18 0.0002
531 VITAMIN D DEFICIENCY 2 0.0002
532 INCORRECT DOSAGE ADMINISTERED 1 0.0002
533 APPLICATION SITE BURN 1 0.0002
534 PANCREATIC DISORDER 1 0.0002
535 SKIN HAEMORRHAGE 3 0.0002
536 ABDOMINAL TENDERNESS 1 0.0002
537 TREATMENT NONCOMPLIANCE 11 0.0002
538 HEPATIC ENZYME ABNORMAL 1 0.0002
539 HYPOTONIA 2 0.0002
540 FLUID INTAKE REDUCED 1 0.0002
541 BRAIN INJURY 2 0.0002
542 ECONOMIC PROBLEM 3 0.0002
543 EXTRA DOSE ADMINISTERED 8 0.0002
544 ABDOMINAL DISCOMFORT 33 0.0002
545 SUBARACHNOID HAEMORRHAGE 2 0.0002
546 DRUG DISPENSING ERROR 3 0.0002
547 DRUG ADMINISTRATION ERROR 6 0.0002
548 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
549 ENDOCARDITIS 1 0.0002
550 THERAPY CESSATION 10 0.0002
551 ABDOMINAL PAIN UPPER 40 0.0002
552 CRYING 7 0.0002
553 CONSTIPATION 42 0.0002
554 APLASTIC ANAEMIA 1 0.0002
555 CYANOSIS 3 0.0002
556 FOOD CRAVING 1 0.0002
557 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
558 NYSTAGMUS 1 0.0002
559 ANAL FISTULA 1 0.0002
560 LOSS OF CONSCIOUSNESS 24 0.0002
561 JOINT INJURY 4 0.0002
562 FOOD POISONING 1 0.0002
563 INJECTION SITE DISCHARGE 1 0.0002
564 FEAR 5 0.0002
565 DISTURBANCE IN ATTENTION 10 0.0002
566 UNEVALUABLE EVENT 14 0.0002
567 BEHAVIOUR DISORDER 1 0.0002
568 SKIN LACERATION 2 0.0002
569 MYALGIA 31 0.0002
570 SEIZURE 21 0.0002
571 PAIN 111 0.0002
572 HEART RATE ABNORMAL 1 0.0002
573 SKIN INFECTION 2 0.0002
574 ACUTE PULMONARY OEDEMA 1 0.0002
575 INTESTINAL PERFORATION 2 0.0002
576 ABNORMAL BEHAVIOUR 7 0.0002
577 SCAR 3 0.0002
578 PARANOIA 3 0.0002
579 MOUTH SWELLING 1 0.0002
580 PALPITATIONS 20 0.0002
581 ENERGY INCREASED 1 0.0002
582 ODYNOPHAGIA 1 0.0002
583 CONFUSIONAL STATE 27 0.0002
584 ACCIDENTAL OVERDOSE 6 0.0002
585 DRUG ABUSER 1 0.0002
586 MEDICATION ERROR 9 0.0002
587 ILEUS 2 0.0002
588 INFUSION SITE EXTRAVASATION 1 0.0002
589 FOOT FRACTURE 3 0.0002
590 INFLUENZA LIKE ILLNESS 13 0.0002
591 BURNING SENSATION 11 0.0002
592 MOOD SWINGS 5 0.0002
593 ENTERITIS 1 0.0002
594 INFUSION SITE PAIN 2 0.0002
595 DYSTONIA 3 0.0002
596 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
597 RASH GENERALISED 4 0.0002
598 BONE PAIN 9 0.0002
599 SKIN FISSURES 3 0.0002
600 SEDATION 4 0.0002
601 GASTRITIS 4 0.0002
602 ORAL CANDIDIASIS 2 0.0002
603 DISORIENTATION 6 0.0002
604 DEPRESSED MOOD 8 0.0002
605 UPPER LIMB FRACTURE 3 0.0002
606 BREAST MASS 1 0.0001
607 FEEDING DISORDER 3 0.0001
608 GINGIVAL BLEEDING 2 0.0001
609 EYE MOVEMENT DISORDER 1 0.0001
610 RIB FRACTURE 3 0.0001
611 ONYCHOCLASIS 1 0.0001
612 ADVERSE DRUG REACTION 13 0.0001
613 ENCEPHALITIS 1 0.0001
614 NIGHTMARE 5 0.0001
615 DIZZINESS 72 0.0001
616 LARGE INTESTINE PERFORATION 1 0.0001
617 HUNGER 2 0.0001
618 URTICARIA 24 0.0001
619 DEFAECATION URGENCY 1 0.0001
620 APPLICATION SITE REACTION 1 0.0001
621 HAND FRACTURE 1 0.0001
622 CARDIOGENIC SHOCK 2 0.0001
623 AMNESIA 9 0.0001
624 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
625 MOUTH HAEMORRHAGE 1 0.0001
626 MUSCLE SPASMS 25 0.0001
627 PRODUCT DOSE OMISSION ISSUE 40 0.0001
628 INFLAMMATION 7 0.0001
629 DYSGEUSIA 10 0.0001
630 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
631 HAEMORRHAGE INTRACRANIAL 2 0.0001
632 BONE LOSS 2 0.0001
633 DYSARTHRIA 5 0.0001
634 HALLUCINATION 10 0.0001
635 HOT FLUSH 10 0.0001
636 HYPOAESTHESIA ORAL 2 0.0001
637 APHASIA 4 0.0001
638 HEPATOCELLULAR CARCINOMA 1 0.0001
639 DISCOMFORT 8 0.0001
640 HYPERTHERMIA 1 0.0001
641 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
642 DISSOCIATION 1 0.0001
643 FOOD ALLERGY 1 0.0001
644 CONCUSSION 1 0.0001
645 DELUSION 2 0.0001
646 NICOTINE DEPENDENCE 1 0.0001
647 THERAPY PARTIAL RESPONDER 2 0.0001
648 THERAPY INTERRUPTED 9 0.0001
649 LOW BIRTH WEIGHT BABY 1 0.0001
650 TACHYCARDIA 11 0.0001
651 FRUSTRATION TOLERANCE DECREASED 1 0.0001
652 MUSCLE TIGHTNESS 2 0.0001
653 OFF LABEL USE 108 0.0001
654 PRODUCT DOSE OMISSION 8 0.0001
655 HICCUPS 1 0.0001
656 MULTIPLE FRACTURES 2 0.0001
657 EMBOLISM 1 0.0001
658 AGEUSIA 3 0.0001
659 LIP SWELLING 4 0.0001
660 URINARY RETENTION 4 0.0001
661 DRUG INTERACTION 19 0.0001
662 ASTHENIA 45 0.0001
663 LIVE BIRTH 1 0.0001
664 SURGERY 7 0.0001
665 INFUSION SITE ERYTHEMA 1 0.0001
666 HEMIPARESIS 2 0.0001
667 CARDIAC DISORDER 11 0.0001
668 SWELLING 11 0.0001
669 HYPOPHAGIA 3 0.0001
670 PERIPHERAL SWELLING 18 0.0001
671 GASTRIC DISORDER 4 0.0001
672 DRUG INEFFECTIVE 153 0.0001
673 OEDEMA PERIPHERAL 14 0.0001
674 NAIL DISORDER 1 0.0001
675 BLOOD CALCIUM INCREASED 1 0.0001
676 GRIP STRENGTH DECREASED 1 0.0001
677 SLEEP DISORDER 8 0.0001
678 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
679 VISUAL IMPAIRMENT 14 0.0001
680 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
681 GASTROINTESTINAL INFECTION 1 0.0001
682 THROAT IRRITATION 5 0.0001
683 LOSS OF LIBIDO 1 0.0001
684 HEART RATE INCREASED 11 0.0001
685 GASTROENTERITIS VIRAL 2 0.0001
686 OROPHARYNGEAL DISCOMFORT 1 0.0001
687 OEDEMA 6 0.0001
688 LEUKOCYTOSIS 2 0.0001
689 CARDIAC ARREST 9 0.0001
690 SKIN DISCOLOURATION 5 0.0001
691 ABNORMAL DREAMS 3 0.0001
692 NERVE COMPRESSION 1 0.0001
693 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
694 DECREASED APPETITE 25 0.0001
695 NECK PAIN 6 0.0001
696 WOUND 3 0.0001
697 MIDDLE INSOMNIA 2 0.0001
698 COGNITIVE DISORDER 5 0.0001
699 FLANK PAIN 1 0.0001
700 PHOTOPHOBIA 2 0.0001
701 LACERATION 1 0.0001
702 DYSPNOEA EXERTIONAL 4 0.0001
703 DISEASE RECURRENCE 5 0.0001
704 BALANCE DISORDER 9 0.0001
705 HYPERTENSION 22 0.0001
706 DIZZINESS POSTURAL 1 0.0001
707 AUTOIMMUNE DISORDER 1 0.0001
708 HYPERSENSITIVITY 19 0.0001
709 VISION BLURRED 14 0.0001
710 COELIAC DISEASE 1 0.0001
711 KNEE OPERATION 1 0.0001
712 DYSPEPSIA 10 0.0001
713 PSYCHOTIC DISORDER 3 0.0001
714 URINARY INCONTINENCE 3 0.0001
715 LIGAMENT SPRAIN 1 0.0001
716 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
717 INCORRECT DOSE ADMINISTERED 23 0.0001
718 BLADDER DISORDER 1 0.0001
719 AGGRESSION 5 0.0001
720 ABORTION SPONTANEOUS 4 0.0001
721 PREMATURE BABY 3 0.0001
722 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
723 BACK PAIN 23 0.0001
724 DRY THROAT 1 0.0001
725 EAR DISCOMFORT 1 0.0001
726 SPEECH DISORDER 5 0.0001
727 DYSPNOEA 54 0.0001
728 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
729 EATING DISORDER 2 0.0001
730 HEREDITARY ANGIOEDEMA 1 0.0001
731 HYPOACUSIS 4 0.0001
732 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
733 ASPIRATION 1 0.0001
734 GASTROINTESTINAL PAIN 1 0.0001
735 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
736 FOOT DEFORMITY 1 0.0001
737 INFECTION 13 0.0001
738 GAIT INABILITY 3 0.0001
739 RASH 39 0.0001
740 THERAPY NON-RESPONDER 4 0.0001
741 CHROMATURIA 2 0.0001
742 CHEST DISCOMFORT 9 0.0001
743 DERMATITIS CONTACT 1 0.0001
744 TINNITUS 4 0.0001
745 HYPOKALAEMIA 4 0.0001
746 METASTASES TO LUNG 1 0.0001
747 CHEST PAIN 16 0.0001
748 EYELID OEDEMA 1 0.0001
749 CAESAREAN SECTION 1 0.0001
750 HEART RATE DECREASED 3 0.0001
751 DIARRHOEA 55 0.0001
752 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
753 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
754 BLOOD IRON DECREASED 1 0.0001
755 MUSCLE RIGIDITY 1 0.0001
756 BLOOD PRESSURE FLUCTUATION 2 0.0001
757 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
758 HYPOGLYCAEMIA 4 0.0001
759 BURSITIS 1 0.0001
760 ADRENAL INSUFFICIENCY 1 0.0001
761 PRESYNCOPE 2 0.0001
762 FEELING HOT 5 0.0001
763 ENCEPHALOPATHY 2 0.0001
764 EYE SWELLING 3 0.0001
765 HEPATIC FUNCTION ABNORMAL 3 0.0001
766 EPISTAXIS 6 0.0001
767 SYNCOPE 8 0.0001
768 CELLULITIS 4 0.0001
769 ABDOMINAL PAIN LOWER 2 0.0001
770 INJECTION SITE IRRITATION 1 0.0001
771 FATIGUE 61 0.0001
772 SINUSITIS 8 0.0001
773 ERECTILE DYSFUNCTION 2 0.0001
774 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
775 ABDOMINAL PAIN 18 0.0001
776 SKIN ULCER 2 0.0001
777 DIPLOPIA 2 0.0001
778 SWELLING FACE 5 0.0001
779 RESPIRATORY TRACT INFECTION 2 0.0001
780 INCORRECT PRODUCT STORAGE 1 0.0001
781 ADVERSE REACTION 1 0.0001
782 BLOOD PRESSURE DECREASED 5 0.0001
783 EYE HAEMORRHAGE 1 0.0001
784 HAIR TEXTURE ABNORMAL 1 0.0001
785 JOINT SWELLING 9 0.0001
786 PAIN OF SKIN 2 0.0001
787 THROAT TIGHTNESS 2 0.0001
788 PSORIATIC ARTHROPATHY 3 0.0001
789 NEUROPATHY PERIPHERAL 7 0.0001
790 IMPAIRED GASTRIC EMPTYING 1 0.0001
791 AKATHISIA 1 0.0001
792 CONDITION AGGRAVATED 22 0.0001
793 ACUTE KIDNEY INJURY 11 0.0001
794 HAEMOPTYSIS 2 0.0001
795 COORDINATION ABNORMAL 1 0.0001
796 APHONIA 1 0.0001
797 CARPAL TUNNEL SYNDROME 1 0.0001
798 BLOOD TEST ABNORMAL 1 0.0001
799 INJURY 5 0.0001
800 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
801 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
802 FLATULENCE 4 0.0001
803 HYPOKINESIA 1 0.0001
804 RESPIRATORY FAILURE 5 0.0001
805 GASTROENTERITIS 1 0.0001
806 DYSPHONIA 4 0.0001
807 PAIN IN EXTREMITY 20 0.0001
808 ACUTE MYOCARDIAL INFARCTION 2 0.0001
809 PRURITUS 26 0.0001
810 WEIGHT INCREASED 15 0.0001
811 RESPIRATORY DISORDER 2 0.0001
812 HYPOAESTHESIA 10 0.0001
813 HEPATIC FAILURE 2 0.0001
814 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
815 OSTEOPENIA 1 0.0001
816 MEMORY IMPAIRMENT 9 0.0001
817 BLOOD PRESSURE INCREASED 10 0.0001
818 NEPHROLITHIASIS 3 0.0001
819 HIP ARTHROPLASTY 1 0.0001
820 DEVICE ADHESION ISSUE 1 0.0001
821 OROPHARYNGEAL PAIN 6 0.0001
822 LIMB DISCOMFORT 2 0.0001
823 MUSCULOSKELETAL CHEST PAIN 1 0.0001
824 WEIGHT DECREASED 18 0.0001
825 DYSPHAGIA 6 0.0001
826 HEAD INJURY 2 0.0001
827 FALL 21 0.0001
828 ABSCESS 1 0.0001
829 HYPOTHYROIDISM 2 0.0001
830 CONTUSION 6 0.0001
831 HIP FRACTURE 2 0.0001
832 BACK DISORDER 1 0.0001
833 IMPAIRED HEALING 2 0.0001
834 STAPHYLOCOCCAL INFECTION 2 0.0001
835 VISUAL ACUITY REDUCED 2 0.0001
836 SKIN DISORDER 2 0.0001
837 BLOOD UREA INCREASED 1 0.0001
838 EYE PRURITUS 2 0.0001
839 FACE OEDEMA 1 0.0001
840 CANDIDA INFECTION 1 0.0001
841 FLUSHING 6 0.0001
842 CIRCULATORY COLLAPSE 1 0.0001
843 HOSPITALISATION 9 0.0001
844 HAEMATURIA 2 0.0001
845 MUSCULOSKELETAL DISCOMFORT 1 0.0001
846 DEVICE USE ERROR 2 0.0001
847 ABDOMINAL DISTENSION 6 0.0001
848 GAIT DISTURBANCE 11 0.0001
849 ORTHOSTATIC HYPOTENSION 1 0.0001
850 ECZEMA 3 0.0001
851 DEVICE USE ISSUE 1 0.0001
852 NEUROTOXICITY 1 0.0001
853 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
854 GALLBLADDER DISORDER 1 0.0001
855 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
856 ARTHRALGIA 23 0.0001
857 BLOOD GLUCOSE ABNORMAL 1 0.0001
858 INFLUENZA 6 0.0001
859 HEPATIC STEATOSIS 1 0.0001
860 OXYGEN SATURATION DECREASED 3 0.0001
861 HEPATIC CIRRHOSIS 1 0.0001
862 ASTHMA 6 0.0001
863 RHEUMATOID ARTHRITIS 6 0.0001
864 FRACTURE 1 0.0001
865 BLOOD URINE PRESENT 1 0.0001
866 GASTRIC ULCER 1 0.0001
867 DEHYDRATION 7 0.0001
868 DRY SKIN 7 0.0001
869 ACUTE RESPIRATORY FAILURE 1 0.0001
870 HERNIA 1 0.0001
871 EAR PAIN 1 0.0001
872 HAEMORRHOIDS 1 0.0001
873 CHOKING 1 0.0001
874 KIDNEY INFECTION 1 0.0001
875 CATARACT 3 0.0001
876 ILL-DEFINED DISORDER 3 0.0000
877 RENAL IMPAIRMENT 4 0.0000
878 INTENTIONAL OVERDOSE 3 0.0000
879 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
880 FAECES DISCOLOURED 1 0.0000
881 DEVICE DISLOCATION 2 0.0000
882 APPLICATION SITE PAIN 1 0.0000
883 ANGIOEDEMA 2 0.0000
884 LIVER DISORDER 2 0.0000
885 PULMONARY OEDEMA 2 0.0000
886 PARAESTHESIA 7 0.0000
887 APPLICATION SITE PRURITUS 1 0.0000
888 HEPATIC ENZYME INCREASED 3 0.0000
889 NASOPHARYNGITIS 8 0.0000
890 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
891 RENAL DISORDER 2 0.0000
892 PRODUCTIVE COUGH 2 0.0000
893 NEURALGIA 1 0.0000
894 URINARY TRACT INFECTION 7 0.0000
895 LUNG DISORDER 2 0.0000
896 ALOPECIA 8 0.0000
897 PYREXIA 14 0.0000
898 COVID-19 7 0.0000
899 HYPOTENSION 8 0.0000
900 CHRONIC KIDNEY DISEASE 3 0.0000
901 HAEMATEMESIS 1 0.0000
902 CARDIOVASCULAR DISORDER 1 0.0000
903 DEAFNESS 1 0.0000
904 APPLICATION SITE ERYTHEMA 1 0.0000
905 JOINT STIFFNESS 1 0.0000
906 ANHEDONIA 1 0.0000
907 PANCREATITIS 2 0.0000
908 EAR INFECTION 1 0.0000
909 CARDIAC FAILURE 3 0.0000
910 PNEUMONIA 12 0.0000
911 PALLOR 1 0.0000
912 DRUG DOSE OMISSION 6 0.0000
913 ARTHROPATHY 2 0.0000
914 PANCYTOPENIA 2 0.0000
915 COUGH 10 0.0000
916 SKIN EXFOLIATION 3 0.0000
917 EYE PAIN 2 0.0000
918 PAIN IN JAW 1 0.0000
919 MUSCULAR WEAKNESS 4 0.0000
920 CONVULSION 2 0.0000
921 EYE IRRITATION 2 0.0000
922 NASAL CONGESTION 2 0.0000
923 LABORATORY TEST ABNORMAL 1 0.0000
924 DEVICE ISSUE 3 0.0000
925 CORONARY ARTERY DISEASE 1 0.0000
926 SUICIDE ATTEMPT 2 0.0000
927 PLEURAL EFFUSION 2 0.0000
928 VERTIGO 2 0.0000
929 INJECTION SITE RASH 1 0.0000
930 EMOTIONAL DISORDER 1 0.0000
931 INJECTION SITE ERYTHEMA 4 0.0000
932 NERVOUS SYSTEM DISORDER 1 0.0000
933 BONE DENSITY DECREASED 1 0.0000
934 CYSTITIS 1 0.0000
935 METABOLIC ACIDOSIS 1 0.0000
936 MOVEMENT DISORDER 1 0.0000
937 DEEP VEIN THROMBOSIS 2 0.0000
938 CHOLELITHIASIS 1 0.0000
939 EXPIRED PRODUCT ADMINISTERED 1 0.0000
940 NEOPLASM MALIGNANT 2 0.0000
941 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
942 HYPERKALAEMIA 1 0.0000
943 LYMPHADENOPATHY 1 0.0000
944 MYELOSUPPRESSION 1 0.0000
945 C-REACTIVE PROTEIN INCREASED 1 0.0000
946 UNDERDOSE 2 0.0000
947 SEPSIS 3 0.0000
948 INTESTINAL OBSTRUCTION 1 0.0000
949 ACNE 2 0.0000
950 ARTHRITIS 2 0.0000
951 CARDIAC FAILURE CONGESTIVE 2 0.0000
952 BLINDNESS 1 0.0000
953 LUNG NEOPLASM MALIGNANT 1 0.0000
954 OSTEOPOROSIS 1 0.0000
955 OSTEOARTHRITIS 1 0.0000
956 DEVICE LEAKAGE 1 0.0000
957 MYOCARDIAL INFARCTION 4 0.0000
958 PRODUCT STORAGE ERROR 2 0.0000
959 MUSCULOSKELETAL STIFFNESS 2 0.0000
960 INJECTION SITE PAIN 7 0.0000
961 OCULAR HYPERAEMIA 1 0.0000
962 COMA 1 0.0000
963 ANAEMIA 4 0.0000
964 ATRIAL FIBRILLATION 2 0.0000
965 DRY EYE 1 0.0000
966 DEATH 17 0.0000
967 FLUID RETENTION 1 0.0000
968 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
969 DERMATITIS ATOPIC 1 0.0000
970 BRADYCARDIA 1 0.0000
971 PLATELET COUNT DECREASED 2 0.0000
972 HAEMATOCHEZIA 1 0.0000
973 HYPONATRAEMIA 1 0.0000
974 CEREBROVASCULAR ACCIDENT 3 0.0000
975 HERPES ZOSTER 1 0.0000
976 BLADDER CANCER 1 0.0000
977 NO ADVERSE EVENT 3 0.0000
978 BLOOD CREATININE INCREASED 1 0.0000
979 PSORIASIS 2 0.0000
980 INFUSION RELATED REACTION 1 0.0000
981 FEBRILE NEUTROPENIA 1 0.0000
982 RENAL FAILURE 2 0.0000
983 NEUTROPENIA 2 0.0000
984 ERYTHEMA 3 0.0000
985 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
986 MOBILITY DECREASED 1 0.0000
987 BRONCHITIS 1 0.0000
988 DIABETES MELLITUS 1 0.0000
989 INJECTION SITE SWELLING 1 0.0000
990 INJECTION SITE BRUISING 1 0.0000
991 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
992 BLOOD GLUCOSE INCREASED 2 0.0000